Compare · KN vs PBAX
KN vs PBAX
Side-by-side comparison of Knowles Corporation (KN) and Phoenix Biotech Acquisition Corp. (PBAX): market cap, price performance, sector, and recent activity on the wire.
Summary
- KN operates in Consumer Staples, while PBAX operates in Industrials - the two are in different parts of the market.
- KN is the larger of the two at $3.19B, about 14.0x PBAX ($227.7M).
- KN has hit the wire 2 times in the past 4 weeks while PBAX has been quiet.
- KN has more recent analyst coverage (4 ratings vs 0 for PBAX).
- Company
- Knowles Corporation
- Phoenix Biotech Acquisition Corp.
- Price
- $38.57+3.52%
- $5.45+14.26%
- Market cap
- $3.19B
- $227.7M
- 1M return
- +14.01%
- -
- 1Y return
- +120.53%
- -
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NYSE
- NASDAQ
- IPO
- 2014
- 2021
- News (4w)
- 2
- 0
- Recent ratings
- 4
- 0
Knowles Corporation
Knowles Corporation designs, manufactures, and sells micro-acoustic, audio processing, and precision device solutions for the mobile consumer electronics, communications, medtech, defense, electric vehicle, and industrial markets. It operates in two segments, Audio and Precision Devices (PD). The Audio segment designs and manufactures audio products, including microphones, balanced armature speakers, and audio processors used in applications that serve the mobile, ear, and Internet of Things markets. The PD segment designs and delivers capacitor products and mmWave radio frequency solutions that are used in applications, such as power supplies and medical implants, satellite communication, and radar systems, as well as for telecommunications infrastructure applications. The company also provides single layer electronic components to the telecommunication, fiber optics, and defense markets. It sells its products directly to original equipment manufacturers and to their contract manufacturers and suppliers, as well as through distributors. The company has operations in Asia, the United States, Europe, other Americas, and internationally. Knowles Corporation was founded in 1946 and is headquartered in Itasca, Illinois.
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
Latest KN
- Senior Vice President & COO Giesecke Daniel J. sold $753,903 worth of shares (20,201 units at $37.32) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 175,855 units (SEC Form 4)
- SEC Form SD filed by Knowles Corporation
- SVP, Chief HR Officer Cabrera Raymond D. exercised 25,210 shares at a strike of $16.77 and covered exercise/tax liability with 17,599 shares, increasing direct ownership by 6% to 134,123 units (SEC Form 4)
- President & CEO Niew Jeffrey exercised 142,857 shares at a strike of $16.77 and sold $4,749,995 worth of shares (142,857 units at $33.25) (SEC Form 4)
- SEC Form 144 filed by Knowles Corporation
- SEC Form 144 filed by Knowles Corporation
- SEC Form 144 filed by Knowles Corporation
- Vice President, Controller Bastarrica Air A. Jr. sold $111,987 worth of shares (3,623 units at $30.91), decreasing direct ownership by 7% to 47,569 units (SEC Form 4)
- Director Li Ye Jane received a gift of 7,424 shares, was granted 6,265 shares and gifted 7,424 shares, increasing direct ownership by 26% to 66,717 units (SEC Form 4)
- Director Wishart Michael S was granted 6,265 shares, increasing direct ownership by 9% to 76,720 units (SEC Form 4)
Latest PBAX
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)
- New insider Corey Daniel claimed ownership of 671,470 shares (SEC Form 3) (Amendment)
- SEC Form D filed by Phoenix Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- SEC Form 4 filed by Laporte Kathleen (Amendment)
- Atwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)
- SEC Form SC 13D/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- Loewy Caroline M acquired 5,828 shares (SEC Form 4)
- Kosacz Barbara acquired 5,828 shares (SEC Form 4)